Navigation Links
Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008
Date:4/22/2008

Findings Include 80% SVR12 Rate with Nitazoxanide-Based Combination Therapy

and New Insights into Mechanism of Action of Nitazoxanide

MILAN, Italy, April 23 /PRNewswire/ -- Romark Laboratories, a privately held biopharmaceutical company, today announced that data from studies of nitazoxanide in chronic hepatitis C virus (HCV) infection are being communicated in four presentations made at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), held in Milan, Italy this week.

"These new studies confirm earlier data suggesting synergistic activity between nitazoxanide and peginterferon in genotype 4 patients and provide a first look at sustained virologic response in a limited number of genotype 1 patients," said Jean-Francois Rossignol, M.D., Director of the Romark Institute for Medical Research and discoverer of nitazoxanide. "These data also provide interesting insights into the mechanism of action of nitazoxanide and confirm previous findings related to its safety."

The four presentations include:

-- An oral presentation, titled, "Randomized Controlled Trial of

Nitazoxanide-Peginterferon-Ribavirin, Nitazoxanide-Peginterferon and

Peginterferon-Ribavirin in the Treatment of Patients with Chronic

Hepatitis C Genotype 4," reported final 24-week post-treatment

sustained virologic response (SVR) rates for the company's STEALTH C-1

trial.

In the trial, 96 treatment-naive patients with chronic hepatitis C

genotype 4 were randomized into three groups to receive either 48 weeks

of standard of care (SOC) treatment (n=40), 12 weeks of nitazoxanide

followed by 36 weeks of nitazoxanide plus peginterferon (a dual regimen,

n=28), or 12 weeks of nitazoxanide followed by 36 weeks of nitazoxanide

plus SOC with peginterferon plus ribavirin (a triple regimen, n=28). An

additional 24 interferon-experi
'/>"/>

SOURCE Romark Laboratories
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
2. Romark Laboratories Raises $18 Million in Institutional Financing
3. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013  Decision Resources, one ... firms for pharmaceutical and healthcare issues, finds ... on key efficacy endpoints, including overall survival ... most influence over surveyed U.S. and European ... positive, HER2-negative breast cancer. The two novel ...
(Date:5/21/2013)... Calif. , May 21, 2013 /PRNewswire/ ... embedded-ultrasound platform, today announced the introduction of ... allows complete network-based communications with all cQuest ... latest embedded-ultrasound technology, including this new capability, ... Sao Paulo, Brazil from May ...
(Date:5/21/2013)...  The North Shore-LIJ Health System is expanding a ... at North Shore University Hospital in Manhasset, ... at Forest Hills (NY) Hospital. ... new pilot program strengthens patient safety by providing hospitals ... first time in the US that remote video auditing ...
Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4
(Date:5/21/2013)... NY (PRWEB) May 21, 2013 ... connects people with trusted services & businesses, announced today ... business Emergency Medical Care. , Emergency Medical Care is ... care services 24 hours a day. The guarantee ... appointment is a promising resource for the neighborhood and ...
(Date:5/21/2013)... Reporter , , MONDAY, May 20 (HealthDay News) -- Young ... a higher risk of getting into car crashes, but ... missed sleep on weekends puts them in even greater ... is another challenge to adolescents that comes with lack ... founder of the Center for Injury Research and Prevention ...
(Date:5/21/2013)... May 21 (HealthDay News) -- Racial disparities exist in ... in the United States, according to a large new ... surgery as part of their initial treatment, researchers found ... to have surgery in the early stages of the ... stage 1 and stage 2 disease than white patients. ...
(Date:5/21/2013)... of physical activity appears to be an independent ... obstructive pulmonary disease (COPD) will end up being ... researchers in Connecticut. The study also corroborates an ... with an increased incidence of hospitalizations among patients ... will be presented at the ATS 2013 International ...
(Date:5/21/2013)... CA (PRWEB) May 21, 2013 After the ... fitness boot camp business Fit Body Boot Camp Goderich ... starting June 3rd at its Goderich fitness center ... Boot Camp’s 1,000 lb. Meltdown Challenge’s goal is to inspire ... 1,000 pounds in 28 days. The fee to participate ...
Breaking Medicine News(10 mins):Health News:Romio Announces Mini Video Series Featuring Local Business Emergency Medical Care 2Health News:Weekend 'Catch-Up' Sleep May Cut Young Drivers' Crash Risk 2Health News:Racial Disparities Seen in U.S. Lung Cancer Treatment 2Health News:Exercise levels may predict hospitalizations in COPD population 2Health News:Goderich Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Goderich Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3
... ... in Christ for A Day of Breast Health Awareness, Education and Screenings , ... Philadelphia, Pa. (Vocus) October 2, 2009 -- ... with Praise is The Cure and the Health Ministry Program will have a day-long celebration ...
... ... with chronic sinusitis and recurring sinus infections. When antibiotics fail they are left with little ... ... SinusWars LLC has been treating sinus related conditions for years and has noticed an increase ...
... "Profile America" feature from the U.S. Census Bureau: , (Logo: ... 2: FIRST GYM INSTRUCTORS , Profile America ... staying fit. Often, they have exercise equipment at home, ... But most people interested in fitness plan their busy ...
... has discovered a new way to classify stomach cancers, ... toward designing more effective treatments and improving long-term survival. ... and represents the second leading cause of cancer deaths ... from patients in Singapore, Australia and the United Kingdom ...
... 1 Two interactive computer tools released today by ... emergency planners and responders select and run alternate care ... a surge in seriously ill patients requiring acute care ... alternate care sites. , Alternate care facilities ...
... ... of hydrolysates, the performance of FBS and the consistency of a defined media. , ... Fort Collins, CO (PRWEB) October 4, ... hamster ovaries) cell line enhancement called Zap-CHO . Zap-CHO is designed to deliver superior ...
Cached Medicine News:Health News:More than 500 Breast Cancer Survivors and Community Supporters to Attend Annual 'Praise is The Cure' Event 2Health News:SinusWars LLC Launches a Successful and All Natural Alternative to Antibiotics in the Fight to Treat Chronic Sinusitis 2Health News:Duke/Singapore scientists find new way to classify gastric cancers 2Health News:New Tools Help Emergency Planners Select Alternate Care Facilities and Transfer Patients During Disasters 2Health News:InVitria Launches Zap-CHO to Enhance CHO Cell Culture Performance 2Health News:InVitria Launches Zap-CHO to Enhance CHO Cell Culture Performance 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: